E&Y Entrepreneurs of the Year announced: life sciences winner is founder of a patient-monitoring device manufacturer
Life sciences runners-up include executives of Spectrum Pharmaceuticals, Dohmen Group and Gauthier Biomedical
The Ernst & Young Entrepreneur of the Year is Joe Kiani, founder and chairman of Masimo Corp., a manufacturer of patient-monitoring devices. The company, founded in his garage, now employs 2,300. The E&Y writeup includes mention of a situation that many pharma manufacturers can sympathize with: clinicians were enthusiastic users of the company’s devices, but “more established companies and group purchasing organizations (GPOs) were reluctant to let Masimo Corporation succeed in the market.”
The finalists include:
- Dr. Rajesh Shrotiya, chairman of Spectrum Pharmaceuticals (Henderson, NV)
- Cynthia LaConte, CEO of Dohmen (Milwaukee)
- Michael and Staci Gauthier, president and VP, respectively, of Gauthier Biomedical (Grafton, WI)
A gala awards ceremony was held in Palm Springs, CA in mid-November, culminating the months-long regional and national competition; awards are also given in nine other business categories. More details are available here.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
